{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T03:14:46Z","timestamp":1770693286209,"version":"3.49.0"},"reference-count":157,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine"],"published-print":{"date-parts":[[2026,1,17]]},"DOI":"10.1080\/17435889.2025.2587714","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T14:36:13Z","timestamp":1762871773000},"page":"305-325","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Nanomedicine in the development of vaccines against Herpesviridae: a narrative review"],"prefix":"10.1080","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7329-1171","authenticated-orcid":false,"given":"Diana Hsin-Yu","family":"Lee","sequence":"first","affiliation":[{"name":"University of British Columbia","place":["Vancouver, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4879-5804","authenticated-orcid":false,"given":"William","family":"Lee","sequence":"additional","affiliation":[{"name":"University of British Columbia","place":["Vancouver, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Horacio","family":"Bach","sequence":"additional","affiliation":[{"name":"University of British Columbia","place":["Vancouver, Canada"]},{"name":"University of British Columbia","place":["Vancouver, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.768461"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.1977057"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00290-09"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15071972"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202310886"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1419634"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14122554"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2021.101142"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yapd.2022.03.010"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/v11050463"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.644664"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.19.10179-10185.2003"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2009.07.007"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1183703"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.3402\/jom.v5i0.22766"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.24171\/j.phrp.2021.0146"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2021.1982373"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.3390\/v15061314"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cnur.2020.05.004"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.3390\/v16020251"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.2217\/fvl.15.85"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.06.027"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad184"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.00099-20"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.19061"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2008.08.028"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0363-5023(09)91128-5"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.76.6.365"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2018.06.005"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1014779614525"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12981-022-00469-w"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1086\/380838"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087993"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1515741"},{"issue":"1","key":"e_1_3_5_37_1","first-page":"5A","article-title":"An update on short-course episodic and prevention therapies for herpes genitalis","volume":"14","author":"Corey L","year":"2007","unstructured":"Corey L, Bodsworth N, Mindel A, et al. An update on short-course episodic and prevention therapies for herpes genitalis. Herpes. 2007;14(Suppl 1):5A\u201311A.","journal-title":"Herpes"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2018.12.002"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.18240\/ijo.2017.11.01"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.12.031"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aaw7083"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.09.079"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.3390\/v15071483"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.3390\/v14030540"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13030271"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25189872"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.06.062"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9121440"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11091475"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-00865-5"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2024.2309985"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13010068"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13030327"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11051003"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virs.2022.06.002"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-025-01093-1"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.4014\/jmb.2308.08008"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00662-13"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009169"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.01.029"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00186-20"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-00821-3"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.03.010"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abf3685"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1530364"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.07.043"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2023.09.011"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-00907-y"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49546-w"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13040360"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100658"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101587"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.5c00701"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.7150\/thno.42494"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8020169"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-015-0415-2"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13770"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007464"},{"issue":"2","key":"e_1_3_5_79_1","first-page":"96","article-title":"Preparation and cytotoxic evaluation of magnetite (Fe3O4) nanoparticles on breast cancer cells and its combinatory effects with doxorubicin used in hyperthermia","volume":"5","author":"Sadeghi-Aliabadi H","year":"2013","unstructured":"Sadeghi-Aliabadi H, Mozaffari M, Behdadfar B, et al. Preparation and cytotoxic evaluation of magnetite (Fe3O4) nanoparticles on breast cancer cells and its combinatory effects with doxorubicin used in hyperthermia. Avicenna J Med Biotechnol. 2013;5(2):96\u2013103.","journal-title":"Avicenna J Med Biotechnol"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10111906"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.3390\/md14050099"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.10.8257-8263.1998"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmats.2021.788373"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.7.6.899-903.2000"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-025-02645-6"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10020184"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.17.9337-9345.2003"},{"key":"e_1_3_5_88_1","unstructured":"BioNTech SE. Phase I randomized observer-blinded 3-part dose escalation and expanded safety and dose evaluation trial to evaluate the safety tolerability and immunogenicity of an investigational prophylactic vaccine for the prevention of genital lesions caused by herpes simplex virus (HSV)-2 and potentially HSV-1 [Internet]. clinicaltrials. gov; Report no.: NCT05432583. 2025 [cited 2025 Oct 23]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05432583"},{"key":"e_1_3_5_89_1","unstructured":"Immorna Biotherapeutics Inc. A phase 1 randomized double-blinded active-controlled 2-dose study to assess the safety and immunogenicity of a herpes zoster (HZ) vaccine JCXH-105 in healthy subjects 50 to 69 years of age. [Internet]. Report no.: NCT05871541. clinicaltrials.gov; 2024 [cited 2025 Oct 23]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05871541"},{"key":"e_1_3_5_90_1","unstructured":"Immorna Biotherapeutics Inc. A phase 2 randomized triple-blinded active-controlled study to assess the safety and immunogenicity of an investigational herpes zoster (HZ) vaccine JCXH-105 in healthy subjects \u2265 50 years of age [Internet]. Report no.: NCT06581575. clinicaltrials.gov; 2025 [cited 2025 Oct 23]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06581575"},{"key":"e_1_3_5_91_1","unstructured":"CSPC Megalith Biopharmaceutical Co. A randomized observer-blind placebo-controlled adaptive phase 1 clinical trial to evaluate the safety and immunogenicity of SYS6017 (a zoster mRNA vaccine) in healthy participants aged 40 years or more [Internet]. Report no.: NCT06954818. clinicaltrials.gov; 2025 [cited 2025 Oct 23]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06954818"},{"key":"e_1_3_5_92_1","unstructured":"Shenzhen Shenxin Biotechnology Co. Ltd. A phase 1 randomized multicenter double-blind dose-ranging study to evaluate the safety reactogenicity and immunogenicity of herpes zoster IN001 mRNA vaccine (IN001) in healthy participants 50 to 69 years old [Internet]. Report no.: NCT06375512. clinicaltrials.gov; 2024 [cited 2025 Oct 23]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06375512"},{"key":"e_1_3_5_93_1","unstructured":"Pfizer. A phase 1&2 randomized observer-blind study to evaluate the safety tolerability and immunogenicity of a modified RNA vaccine against varicella zoster virus in healthy individuals [Internet]. Report no.: NCT05703607. clinicaltrials.gov; 2025 [cited 2025 Oct 23]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05703607"},{"key":"e_1_3_5_94_1","unstructured":"ModernaTX Inc. A phase 1&2 randomized observer-blind active-controlled dose-ranging study to evaluate the safety reactogenicity and immunogenicity of mRNA-1468 a candidate vaccine to prevent herpes zoster (HZ) in healthy adults \u226550 years of age [Internet]. Report no.: NCT05701800. clinicaltrials.gov; 2025 [cited 2025 Oct 23]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05701800"},{"key":"e_1_3_5_95_1","unstructured":"ModernaTX Inc. A phase 1 randomized observer-blind placebo-controlled dose-ranging study to evaluate the safety reactogenicity and immunogenicity of cytomegalovirus vaccines mRNA-1647 and mRNA-1443 when administered to healthy adults. [Internet]. Report no.: NCT03382405. clinicaltrials.gov; 2021 [cited 2025 Oct 23]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03382405"},{"key":"e_1_3_5_96_1","unstructured":"ModernaTX Inc. A phase 2 non-randomized long-term extension study to evaluate the immunogenicity and safety of cytomegalovirus mRNA-1647 vaccine including a booster dose in a subset of participants who completed study mRNA-1647-P202 [Internet]. Report no.: NCT04975893. clinicaltrials.gov; 2025 [cited 2025 Oct 23]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04975893"},{"key":"e_1_3_5_97_1","unstructured":"ModernaTX Inc. A phase 3 randomized observer-blind placebo-controlled study to evaluate the efficacy safety and immunogenicity of mRNA-1647 cytomegalovirus (CMV) vaccine in healthy participants 16 to 40 years of age [Internet]. Report no.: NCT05085366. clinicaltrials.gov; 2025 [cited 2025 Oct 23]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05085366"},{"key":"e_1_3_5_98_1","unstructured":"ModernaTX Inc. A phase 2 observer-blind placebo-controlled proof-of-concept trial to evaluate efficacy safety and immunogenicity of mRNA-1647 cytomegalovirus vaccine in patients who have undergone allogeneic hematopoietic cell transplantation (HCT) [Internet]. Report no.: NCT05683457. clinicaltrials.gov; 2025 [cited 2025 Oct 23]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05683457"},{"key":"e_1_3_5_99_1","unstructured":"VBI Vaccines Inc. A phase 1 randomized observer-blind placebo-controlled study to evaluate the safety tolerability and immunogenicity of the candidate human cytomegalovirus vaccine (VBI-1501) in healthy adults [Internet]. Report no.: NCT02826798. Available from clinicaltrials.gov; 2020 [cited 2025 Oct 23]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT02826798"},{"key":"e_1_3_5_100_1","unstructured":"National Institute of Allergy and Infectious Diseases (NIAID). Phase 1 study of the safety and immunogenicity of an Epstein-Barr virus (EBV) gp350-ferritin nanoparticle vaccine in healthy adults with or without EBV infection [Internet]. Report no.: NCT04645147. clinicaltrials.gov; 2025 [cited 2025 Oct 23]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04645147"},{"key":"e_1_3_5_101_1","unstructured":"National Institute of Allergy and Infectious Diseases (NIAID). A phase 1&2 randomized double-blinded placebo-controlled trial evaluating the immunogenicity and safety of an adjuvanted Epstein-Barr virus (EBV) glycoprotein 350 vaccine in EBV-seronegative persons [Internet]. Report no.: NCT05683834. clinicaltrials.gov; 2025 [cited 2025 Oct 23]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05683834"},{"key":"e_1_3_5_102_1","unstructured":"National Institute of Allergy and Infectious Diseases (NIAID). Phase 1 study of the safety of an Epstein-Barr virus (EBV) gH&gL&gp42-ferritin nanoparticle vaccine with or without gp350-ferritin in healthy adults with or without EBV infection [Internet]. Report no.: NCT06908096. clinicaltrials.gov; 2025 [cited 2025 Oct 23]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06908096"},{"key":"e_1_3_5_103_1","unstructured":"ModernaTX Inc. A phase 1&2 randomized observer-blind placebo-controlled dose-ranging study of an Epstein-Barr virus (EBV) candidate vaccine mRNA-1189 in 10- to 30-year-old healthy adolescents and adults [Internet]. Report no.: NCT05164094. clinicaltrials.gov; 2025 [cited 2025 Oct 23]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05164094"},{"key":"e_1_3_5_104_1","unstructured":"ModernaTX Inc. A phase 1 randomized observer-blind placebo-controlled 2-part dose-ranging study of an EBV candidate vaccine mRNA-1195 in healthy participants 18 through 55 years of age [Internet]. Report no.: NCT05831111. clinicaltrials.gov; 2025 [cited 2025 Oct 23]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05831111"},{"key":"e_1_3_5_105_1","doi-asserted-by":"publisher","DOI":"10.3390\/v15020439"},{"key":"e_1_3_5_106_1","doi-asserted-by":"publisher","DOI":"10.3390\/v14020192"},{"key":"e_1_3_5_107_1","doi-asserted-by":"publisher","DOI":"10.3390\/v15081663"},{"key":"e_1_3_5_108_1","doi-asserted-by":"publisher","DOI":"10.3390\/v14050982"},{"key":"e_1_3_5_109_1","doi-asserted-by":"publisher","DOI":"10.1086\/655136"},{"key":"e_1_3_5_110_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0221084"},{"key":"e_1_3_5_111_1","doi-asserted-by":"publisher","DOI":"10.3390\/v13102018"},{"key":"e_1_3_5_112_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16666"},{"key":"e_1_3_5_113_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1403062"},{"key":"e_1_3_5_114_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.16"},{"key":"e_1_3_5_115_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2011"},{"key":"e_1_3_5_116_1","doi-asserted-by":"publisher","DOI":"10.1086\/522156"},{"key":"e_1_3_5_117_1","unstructured":"Canada PHA of. Varicella (chickenpox) vaccines: canadian Immunization Guide [Internet]. 2017 [cited 2025 Aug 7]. Available from: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/canadian-immunization-guide-part-4-active-vaccines\/page-24-varicella-chickenpox-vaccine.html"},{"key":"e_1_3_5_118_1","unstructured":"Canada PHA of. Herpes zoster (shingles) vaccine: canadian immunization guide [Internet]. 2007 [cited 2025 Aug 7]. Available from: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/canadian-immunization-guide-part-4-active-vaccines\/page-8-herpes-zoster-(shingles)-vaccine.html"},{"issue":"175","key":"e_1_3_5_119_1","first-page":"2","article-title":"Camptothecin-discovery, clinical perspectives and biotechnology","volume":"3","author":"Raveendran VV","year":"2015","unstructured":"Raveendran VV. Camptothecin-discovery, clinical perspectives and biotechnology. Nat Prod Chem Res [Internet]. 2015 [cited 2025 Aug 7];3(175):2.","journal-title":"Nat Prod Chem Res [Internet]"},{"key":"e_1_3_5_120_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.03445-13"},{"key":"e_1_3_5_121_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2445384"},{"key":"e_1_3_5_122_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40820-021-00771-8"},{"key":"e_1_3_5_123_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.906457"},{"key":"e_1_3_5_124_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12101112"},{"key":"e_1_3_5_125_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29174221"},{"key":"e_1_3_5_126_1","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202202595"},{"key":"e_1_3_5_127_1","doi-asserted-by":"publisher","DOI":"10.3390\/v12010035"},{"key":"e_1_3_5_128_1","doi-asserted-by":"publisher","DOI":"10.3390\/v13061078"},{"key":"e_1_3_5_129_1","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-024-00226-7"},{"key":"e_1_3_5_130_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/144.1.47"},{"key":"e_1_3_5_131_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-021-00582-z"},{"key":"e_1_3_5_132_1","doi-asserted-by":"publisher","DOI":"10.1159\/000018381"},{"key":"e_1_3_5_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogc.2023.02.002"},{"key":"e_1_3_5_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2022.100641"},{"key":"e_1_3_5_135_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu969"},{"key":"e_1_3_5_136_1","doi-asserted-by":"publisher","DOI":"10.1086\/649903"},{"key":"e_1_3_5_137_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2023.07.022"},{"key":"e_1_3_5_138_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2024.113934"},{"key":"e_1_3_5_139_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/24.1.52"},{"key":"e_1_3_5_140_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jp.7211578"},{"key":"e_1_3_5_141_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12080-1"},{"key":"e_1_3_5_142_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2015.05.003"},{"key":"e_1_3_5_143_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf8818"},{"key":"e_1_3_5_144_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1123805"},{"key":"e_1_3_5_145_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad593"},{"key":"e_1_3_5_146_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.12.019"},{"key":"e_1_3_5_147_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111407"},{"key":"e_1_3_5_148_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.08.026"},{"key":"e_1_3_5_149_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.587380"},{"key":"e_1_3_5_150_1","doi-asserted-by":"publisher","DOI":"10.3390\/v15030714"},{"key":"e_1_3_5_151_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-023-02187-9"},{"key":"e_1_3_5_152_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.105037"},{"key":"e_1_3_5_153_1","doi-asserted-by":"publisher","DOI":"10.3390\/biom11091380"},{"key":"e_1_3_5_154_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30541"},{"key":"e_1_3_5_155_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/174.2.324"},{"key":"e_1_3_5_156_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103699"},{"key":"e_1_3_5_157_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2008.03699.x"},{"key":"e_1_3_5_158_1","doi-asserted-by":"publisher","DOI":"10.3390\/v11060502"},{"key":"e_1_3_5_159_1","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.437"}],"container-title":["Nanomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17435889.2025.2587714","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:22:35Z","timestamp":1767705755000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17435889.2025.2587714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":157,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1,17]]}},"alternative-id":["10.1080\/17435889.2025.2587714"],"URL":"https:\/\/doi.org\/10.1080\/17435889.2025.2587714","relation":{},"ISSN":["1743-5889","1748-6963"],"issn-type":[{"value":"1743-5889","type":"print"},{"value":"1748-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=innm20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=innm20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-09-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}